GH Research PLC (GHRS) stock
GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.27−0.48 (-2.56%)
Close on Nov 17, 2026Market cap $1.13BP/E –Yield –
GH Research enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
GH Research's enterprise value was $870.77M on Nov 11, 2026, against $637.64M a year earlier. Over the last 5 years it ranged from $111.57M to $1.50B, with a median of $456.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $870.77M | +76.4% |
| 2025 | Dec 31, 2025 | $493.66M | +80.1% |
| 2024 | Dec 31, 2024 | $274.14M | +27.3% |
| 2023 | Dec 29, 2023 | $215.28M | +45.6% |
| 2022 | Dec 30, 2022 | $147.83M | -77.5% |
| 2021 | Dec 31, 2021 | $655.73M | – |
See a number that looks wrong?